Clinical Trial Update: PPIO-009 Tumor Regression Grade and Tumor Location in Esophageal Cancer

View source ↗

Summary

A completed clinical trial (NCT06453395) investigating PPIO-009 in esophageal cancer focused on tumor regression grade and tumor location.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer

Snippet

Sponsor: Daping Hospital and the Research Institute of Surgery of the Third Military Medical University | Conditions: Tumor Regression Grade | Status: COMPLETED